Virtu Financial’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-5,103
| Closed | -$23K | – | 2557 |
|
2022
Q2 | $23K | Buy |
5,103
+1,921
| +60% | +$8.66K | ﹤0.01% | 1309 |
|
2022
Q1 | $33K | Sell |
3,182
-5,196
| -62% | -$53.9K | ﹤0.01% | 1226 |
|
2021
Q4 | $125K | Buy |
+8,378
| New | +$125K | 0.01% | 1034 |
|
2021
Q3 | – | Sell |
-1,517
| Closed | -$51K | – | 2359 |
|
2021
Q2 | $51K | Buy |
1,517
+270
| +22% | +$9.08K | 0.01% | 1333 |
|
2021
Q1 | $52K | Buy |
1,247
+365
| +41% | +$15.2K | ﹤0.01% | 1431 |
|
2020
Q4 | $53K | Buy |
+882
| New | +$53K | 0.01% | 1221 |
|
2020
Q3 | – | Sell |
-248
| Closed | -$42K | – | 1763 |
|
2020
Q2 | $42K | Buy |
+248
| New | +$42K | ﹤0.01% | 1026 |
|
2018
Q2 | – | Sell |
-130
| Closed | -$164K | – | 2698 |
|
2018
Q1 | $164K | Sell |
130
-157
| -55% | -$198K | 0.01% | 1436 |
|
2017
Q4 | $429K | Buy |
+287
| New | +$429K | 0.02% | 956 |
|